News & Events

Pancreatic Cancer Education Day for Patients and Their Supporters

Pancreas Centre BC and Pancreatic Cancer Canada will host an education day for patients with pancreatic cancer, their families and supporters.  The program will include:

  • An overview of pancreatic cancer
  • Surgery
  • Research & clinical trials
  • Screening & surveillance
  • Hereditary cancer
  • Nutrition and support
  • Patient stories
  • Your questions answered

The details of the symposium are:

Date: Saturday 5th December 2015

Dr. Shoukat Dedhar’s team receives $1.25 million IMPACT grant

The research team led by Dr. Shoukat Dedhar, a distinguished scientist at BC Cancer Agency and a Pancreas Centre BC 2013 IDEAS grant recipient,  was awarded a Canadian Cancer Society Impact Grant for the project entitled ‘New therapeutic strategy targeting tumour hypoxia and carbonic anhydrase IX for the treatment of pancreatic cancer’.

Announcement of the recipients of the 2014 IDEAS Grants

The Pancreas Centre BC is pleased to announce the winners of the recent 2014 IDEAS Grants program competition. This research funding program was made possible by the generous donations from private donors. The centre has received 11 applications and the research advisory committee recommended four proposals for funding. Pancreas Centre BC anticipates that the funds invested into the projects will accelerate leading edge research aimed at understanding and treating pancreatic cancer.

Congratulations to the 2014 IDEAS grant recipients:

Robert Holt      

Pancreas Centre BC Researchers Receive Innovation Grants!

In November 2014 two studies led by Pancreas Centre BC researchers received National Pancreatic Cancer Foundation Innovation Grants.

The first study entitled ‘The effects of neoadjuvant metformin on tumour cell proliferation and tumour progression in pancreatic ductal adenocarcinoma’ is led by Drs. Dan Renouf, David Schaeffer, James Johnson and Janel Kopp. The study will investigate the effects of metformin on tumour cell proliferation and tumour progression in pancreatic ductal adenocarinoma.  Patients with resectable disease will be treated with metformin prior to surgery.


Subscribe to News & Events